(Q52622604)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22390487%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

Abatacept in the long-term treatment of rheumatoid arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22390487%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22390487%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

2

Kimme L Hyrich

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22390487%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

publication date

1 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22390487%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Clinical Immunology

25 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22390487%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22390487%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22390487%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

231-234

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22390487%20AND%20SRC:MED&resulttype=core&format=json

Biologic therapy for rheumatoid arthritis: clinical efficacy and predictors of response

25 January 2020

cites work

1 reference

Cytokine pathways and joint inflammation in rheumatoid arthritis

21 January 2018

1 reference

Abatacept for rheumatoid arthritis: a Cochrane systematic review

21 January 2018

1 reference

Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial

21 January 2018

1 reference

Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trial

21 January 2018

1 reference

Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with specia

21 January 2018

1 reference

Treatment benefit or survival of the fittest: what drives the time-dependent decrease in serious infection rates under TNF inhibition and what does this imply for the individual patient?

21 January 2018

1 reference

Clinical response and tolerability to abatacept in patients with rheumatoid arthritis previously treated with infliximab or abatacept: open-label extension of the ATTEST Study

21 January 2018

1 reference

Subcutaneous abatacept versus intravenous abatacept: a phase IIIb noninferiority study in patients with an inadequate response to methotrexate.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ECI.11.98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22390487%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference